Priyanka Raheja: Sharing the Final Analysis From the Roctavian Phase 1/2 Study
Priyanka Raheja, Director at The Royal London Hospital Haemophilia Comprehensive Care Centre, shared EAHAD’s post on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia Journal, adding:
“Sharing the final analysis from the Roctavian phase 1/2 study.
Despite the sad news of market withdrawal, the long term follow up of the first people who participated in this trial continues to provide important learnings.”
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Check the article recently published on our official journal on ‘Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A’.
Take a closer look at the data on the Haemophilia Journal.”
Title: Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A
Authors: Priyanka Raheja, Savita Rangarajan, Will Lester, Bella Madan, Glenn F. Pierce, Emily Symington, Carolyn Millar, Dane Osmond, Mingjin Li, Konstantia-Maria Chavele
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 15, 2026, 23:35Katya McCarthy: From Lab Specialist to Patient – Facing Polycythemia and Venous Thrombosis
-
Sep 15, 2026, 23:19Narat Srivali: Chronic Preoperative Corticosteroid Use Associated with 51% Higher Postoperative VTE Risk
-
Sep 15, 2026, 23:13Grace M Thomas: Join 3rd edition of the Neutrophil Club of SFI Webinar Series on Thromboinflammation
-
Sep 15, 2026, 23:05Noha K Hashmi: Honoured to Present 2 Case-Based Posters at the 5th MENA Conference for Rare Diseases 2026
-
Sep 15, 2026, 22:56Susan Slingluff Hartmann: How NBDF and the BDRC Are Putting Lived Experience at the Heart of Studies
-
Sep 15, 2026, 22:50Shehab Mohamed: New GCC Consensus Recommendations for the Diagnosis and Management of HLH
-
Sep 15, 2026, 22:42100 Years of von Willebrand Disease: What Has a Century of Progress Taught Us? – EAHAD
-
Sep 15, 2026, 22:38Cedric Hermans: How Iis TFPI Inhibition Changing Haemophilia Care?
-
Sep 15, 2026, 17:33Reza Shojaei: Blood and Plasma Donors Are Not a Production Metric